VBVladimir V. Bazarnyi

Vladimir V. Bazarnyi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vladimir V. Bazarnyi has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fucoxanthin as a Geroprotector: Experimental Data on Mice

    by A. I. Kapralov, I. Yu. Maklakova, D. Yu. Grebnev, V. V. Bazarnyj, S. I. Krivenko

    Introduction . Th e search for compounds capable of modulating key mechanisms of aging remains one of the pressing challenges of modern medicine. Fucoxanthin, a carotenoid derived from brown algae, possesses antioxidant and anti-infl ammatory properties; however, its eff ects on complex biomarkers of aging in mammals remain insuffi ciently studied. Objective is to comprehensively evaluate the eff ects of long-term oral administration of fucoxanthin on biomarkers of aging, including pro-infl ammatory cytokines, advanced glycation end products, and metabolic parameters in aging mice. Materials and methods . Th e study included 30 male ICR/CD1 mice divided into three groups: 1) mature controls (10 months), 2) aged controls (18 months), and 3) aged mice receiving fucoxanthin (18 months) at a dose of 20 mg/kg body weight per day for 8 months. Serum levels of IL-6, TNF-α, MCP-1, and AGEs, as well as biochemical parameters, were assessed. Results . In aged control mice, all measured markers were signifi cantly higher than in mature controls. Fucoxanthin administration contributed to a reduction in IL-6, TNF-α, MCP-1, and AGEs levels, along with an improvement in the metabolic profi le (decreased glucose, triglycerides, ALT and AST activities, and increased HDL cholesterol and albumin). Conclusion . Th e obtained results demonstrate a comprehensive geroprotective eff ect of fucoxanthin, refl ected in suppression of the senescence-associated secretory phenotype, reduction of carbonyl stress, and improvement of metabolic status. Th ese fi ndings support the potential of fucoxanthin as a promising geroprotector for further research in the prevention of age-associated diseases.

  • Study of the state of the cardiovascular system in laboratory animals after chronic inhalation exposure to lead oxide nanoparticles

    by Ilzira A. Minigalieva, Marina P. Sutunkova, Maksim A. Kopenkin, Maria S. Unesikhina, Ekaterina M. Petrunina, Vladimir V. Bazarnyi

    Introduction. Current data indicate that lead oxide nanoparticles have a more pronounced toxicity compared to microparticles, organic and inorganic lead salts. Lead intoxication is a significant risk factor for the development of cardiovascular diseases. The features of the cardiotoxic effect of lead oxide nanoparticles require further study.The study aims to evaluate changes in clinical, functional, and metabolic parameters characterizing the state of the cardiovascular system during inhalation exposure to lead oxide nanoparticles for 4 months.Materials and methods. The authors conducted an experiment on female rats divided into two equal groups: the main group (n=10) and the control group (n=10). The experimental group was exposed to lead oxide nanoparticles by inhalation at a concentration of 0.2 mg/m³ for 4 months. An electrocardiogram and blood pressure were recorded. Histological examination and metabolomic analysis of heart tissue were performed. The concentration of coproporphyrin and delta-aminolevulinic acid in urine was determined.Results. The scientists found an increase in pulse pressure (p=0.020), a reduction in the QT interval in the first lead (p=0.027) and the QRS complex in the second (p=0.020). There was an increase in the size of cardiomyocytes (p<0.001). Metabolic analysis of heart tissue revealed an increase in the levels of proline (p=0.019), adenine (p=0.010), methionine sulfoxide (p=0.038), succinyl adenosine (p=0.019), linoleic acid (p=0.010), lysophosphatidylethanolamines 18:0 and 18:1 (p=0.010 and p=0.038, respectively) and lysophosphatidylcholines 18:1 and 18:2 (p=0.038 and p=0.038).Limitations. This work does not take into account possible intersex and interspecific differences.Conclusion. The results of the study showed that exposure to lead oxide nanoparticles causes changes in blood pressure, has a proarrhythmogenic effect, contributes to an increase in the size of cardiomyocytes and the development of oxidative stress.Ethics. The study was approved at a meeting of the Local Ethics Committee of the Yekaterinburg Medical Scientific Center for the Prevention and Health Protection of Industrial Workers of Rospotrebnadzor (Protocol No. 4 dated 07/12/2022).Contributions:Minigalieva I.A. — concept and design of research, writing, editing;Sutunkova M.P. — concept and design of research, editing;Kopenkin M.A. — data collection and processing, text writing, editing;Unesikhina M.C. — data collection and processing, text writing, editing;Petrunina E.M. — data collection and processing;Bazarnyi V.V. — concept and design of research, editing;All co-authors — approving the final version of the article and ensuring the integrity of all parts of the article.Funding. The study had no funding.Conflict of interest. The authors declare no conflict of interest.Received: 07.05.2026 / Accepted: 14.05.2026 / Published: 11.08.2026

  • Open Access

    The Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases

    by M. A. Kopenkin, A. M. Mazmaeva, K. S. Nasonova, E. A. Sementsova, A. Yu. Maksimova, V. V. Bazarnyi, М. А. Копенкин, А. М. Мазмаева, К. С. Насонова, Е. А. Семенцова, et al.

    The Diagnostic Value of Certain Immunoactive Peptides in Oral Diseases | Kopenkin | Ural Medical Journal Клинико-диагностическая ценность некоторых иммуноактивных пептидов при заболеваниях полости рта | Копенкин | Уральский медицинский журнал

  • Open Access

    Clinical and Laboratory Study of a New Immunomodulatory Mouthwash in Inflammatory Periodontal Diseases in Elderly Patients

    by Ju. V. Mandra, V. V. Bazarnyi, С. Г. Майзель, E. A. Sementsova, S. S. Grigoriev, T. M. Yelovikova, M. P. Kharitonova, A. V. Lyogkikh, M. S. Mirzoeva, N. M. Zhegalina, et al.

    Relevance . Elderly patients have a change in immune status. Manifestations of senescent immunodeficiency are present in the oral cavity, aggravate the main dental diseases. Local immunity plays a key role in the effective treatment and prevention of inflammatory diseases in the oral cavity. Materials and methods . A new immunomodulatory mouthwash has been developed based on the “Immunokol LP”. It is created from bovine colostrum products. A clinical study of the effectiveness of a new mouthwash for inflammatory periodontal diseases in elderly patients included determining hygienic and periodontal indices before and after a course of its use. The laboratory study included an analysis of oral fluid parameters (general parameters, inflammatory reaction, local immunity, mineral metabolism). Results . Clinical evaluation of the effectiveness of the new mouthwash showed an improvement in the hygienic condition of the oral cavity of patients, a decrease in the severity of residual inflammation in the periodontal tissues after a course of its use. Laboratory testing of oral fluid showed a mild anti-inflammatory and immunomodulatory effect of the mouthwash, an increase in calcium concentration, calcium-to-phosphorus ratio. Conclusion . The new immunomodulatory mouthwash helps to reduce inflammation in the oral tissues and maintain remission of inflammatory periodontal diseases in elderly patients.


  • Open Access

    Study of the effectiveness of the line products for individual oral hygiene in children with chronic gingivitis and palliative status

    by Д. А. Гинкель, E. N. Svetlakova, Yu. V. Mandra, В. В. Базарный, L. G. Polushina, А. G. Koroleva, M. A. Petrikova

    Background. Periodontal diseases, including chronic gingivitis (ICD-10 code K05.1), are widespread among children and adolescents, especially among patients with palliative status. In this category of patients, oral hygiene is often unsatisfactory due to limited physical abilities and insufficient awareness of parents and medical staff. This leads to a decrease in the quality of life of young patients and the development of oral complications.Materials and methods. The study included 56 adolescents aged 9 to 16 years diagnosed with chronic gingivitis (K05.1) and concomitant somatic diseases. The children were randomly divided into two groups. Patients in the first group were provided with an individualized oral hygiene program using Splat products, while the second group received standard oral hygiene tools. The effectiveness was evaluated based on the dynamics of OHI-S, PMA, PBI indices and the Rosenberg scale for halitosis intensity. Additionally, microbiological analysis of oral mucosa smears was performed.Results. Incorporation of Splat oral care products (bioactive children’s toothpaste, Splat Junior Magic Foam mousse, and Splat Smilex Ortho+ single-tufted brush) into individual oral hygiene routines during comprehensive treatment of chronic gingivitis demonstrated high efficacy, confirmed by objective data and index-based evaluation. Microbiological analysis at baseline revealed a predominance of potentially pathogenic microorganisms (S. viridans, S. aureus, C. albicans), followed by improvement in the oral microbiome composition after comprehensive therapy. Clinical improvements were observed in both groups, indicating effective hygiene care regardless of product type. However, differences between the groups were not statistically significant.Conclusion. Splat oral care products (bioactive children’s toothpaste with calcium hydroxyapatite and Luctatol system, Splat Junior Magic Foam mousse, and Splat Smilex Ortho+ single-tufted brush) can be recommended for widespread use in individual oral hygiene as part of comprehensive treatment of chronic gingivitis in children with palliative status, with prior education and hygiene monitoring.

  • Open Access

    Features of the Lipid Profile in Patients after Acute Pulmonary Embolism

    by K. R. Dorokhina, O. M. Khromtsova, M. I. Fominykh, Y. G. Bozhko, E. V. Kudryavtseva, В. В. Базарный, L. G. Polushina

    Introduction. The question of the effect of lipids on the risk of venous thromboembolism (VTE) currently remains open and debatable. The effect of dyslipidemia on the risk of arterial and venous thrombosis is currently being studied.The aim of the work was to evaluate the parameters of the blood lipids of patients with pulmonary embolism (PE) in the acute period and 1 year after the episode.Materials and methods. A prospective cohort study of lipids — total cholesterol (TCH), low-density lipoproteins (LDL-C), high-density lipoproteins (HDL-C), triglycerides (TG), apolipoproteins A1and B (ApoA1 and ApoB) — was conducted in patients in the acute period PE and after 1 year of follow-up.Results. Patients with PE in the acute period have initially normal levels of THC, LDL-C, TG, ApoA1, ApoB, and low levels of HDL-C. After 1 year of follow-up, the levels of THC, LDL-C, TG, and ApoB exceed normal values, dyslipidemia is detected due to the predominance of LDL-C, and HDL-C levels return to normal.Discussion. Determination of the blood lipids initially and over time allows monitoring changes in the concentration of lipids and correcting dyslipidemia to reduce cardiovascular risk.Conclusion. In the acute period of PE, normal levels of THC, LDL-C, TG, ApoA1, ApoB are noted, but lower in comparison with patients without a history of VTE, low levels of HDL-C. After a year of follow-up, hypercholesterolemia, dyslipidemia due to LDL-C, TG, and ApoB are detected, which creates a cardiovascular risk in these patients and requires correction.

  • Open Access

    Clinical and laboratory evaluation of the effectiveness of toothpastes in elderly patients

    by J. V. Mandra, E. A. Sementsova, V. V. Bazarnyi, S. S. Grigoryev, T. M. Elovikova, M. P. Kharitonova

    Relevance. A key manifestation of oral aging is the onset and progression of periodontal disease. In elderly patients, gingivitis and periodontitis often develop in the context of low-grade chronic inflammation. Individual oral hygiene plays a critical role in the management of gingivitis and periodontitis and in maintaining long-term remission. Given the clinical and pathogenetic characteristics of chronic periodontitis in older adults, oral hygiene products for this population must meet specific functional requirements.Objective. To conduct a clinical and laboratory evaluation of the effectiveness of a custom-formulated toothpaste and commercially available formulations in elderly patients diagnosed with gingivitis or periodontitis.Materials and methods. The study enrolled 175 elderly patients diagnosed with chronic periodontitis (ICD-10: K05.3; EFP, 2018 classification: Stage I–II, Grade A–B). All participants underwent a comprehensive dental examination along with laboratory analysis of oral fluid and buccal epithelium. Patients in Study Group 1 used a custom-formulated toothpaste based on a glycerolated silica blend; those in Study Group 2 used a commercially available therapeutic formulation; the comparison group received a placebo toothpaste.Results. Use of the toothpaste containing honeysuckle extract, xylitol, and bromelain resulted in a 43% reduction in the Simplified Oral Hygiene Index (OHI-S) and an 18% reduction in the PMA index. The custom-formulated toothpaste achieved a 23% reduction in OHI-S and a 5% reduction in the PMA index. Furthermore, the effectiveness of the toothpaste containing honeysuckle extract, xylitol, and bromelain was supported by a 58% decrease in C-reactive protein (CRP) levels in oral fluid and a 51% reduction in the apoptosis index.Conclusion. Clinical and laboratory findings in elderly patients showed that the therapeutic toothpaste containing honeysuckle extract, xylitol, and bromelain exhibited the most pronounced cleansing and anti-inflammatory effects.


  • Open Access

    Interpretation of clinical blood tests. Part 3. Monocytes

    by V. V. Bazarnyi, N. F. Klimusheva

    Monocytes are the most important participants in the reactions of innate immunity, mechanisms of tissue damage and repair in cancer, cardiovascular and other diseases. Their evaluation is essential in various pathologic processes. Modern automated blood analysis allows not only to measure the absolute and relative content of these cells, but also to obtain additional information. The lecture deals with monocytic parameters - the number of monocytes, mean monocyte volume (MMV), their volume distribution width (MDW) and other characteristics in various pathologies. The use of flow cytometry makes it possible to obtain data on the cell population of monocytes - average intensity of direct and lateral light scattering of monocytes, average fluorescence intensity, width of light scattering and fluorescence distribution (MO-X, MO-Y, MO-Z, MO-WX, MOWY, MO-WZ). The article shows the changes of the mentioned parameters in different pathology (sepsis, COVID-19, etc.). Some attention is paid to monocyte indices (monocyte/lymphocyte ratio, systemic inflammatory response index - SIRI), which are considered by many authors to be biomarkers of inflammation and have prognostic value in sepsis and other diseases. Modern hematological analyzers expand the possibilities of assessing blood reactions in pathological processes and increase the level of significance of clinical conclusions based on the results of laboratory tests.